de Serres FJ, Blanco I, Fernandez-Bustillo E. Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America. Clin Genet. 2003;64:382–97.
Strnad P, McElvaney NG, Lomas DA. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382:1443–55.
CAS PubMed Article Google Scholar
Miravitlles M, Dirksen A, Ferrarotti I, Koblizek V, Lange P, Mahadeva R, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in alpha1-antitrypsin deficiency. Eur Respir J [Internet]. 2017;50. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29191952.
Willis-Owen SAG, Cookson WOC, Moffatt MF. The genetics and genomics of asthma. Annu Rev Genomics Hum Genet. 2018;19:223–46.
CAS PubMed Article Google Scholar
Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11:404–6.
CDC. NHIS asthma data tables [Internet]. 2017. Available from: https://www.cdc.gov/asthma/nhis/default.htm.
McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ. Diagnosis and management of asthma in adults: a review. 2017;318:279–90.
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143–78.
CAS PubMed Article Google Scholar
Ortega VE, Li X, O’Neal WK, Lackey L, Ampleford E, Hawkins GA, et al. The effects of rare SERPINA1 variants on lung function and emphysema in SPIROMICS. Am J Respir Crit Care Med. 2020;201:540–54.
CAS PubMed PubMed Central Article Google Scholar
Cummings EE, O’Reilly LP, King DE, Silverman RM, Miedel MT, Luke CJ, et al. Deficient and null variants of SERPINA1 are proteotoxic in a Caenorhabditis elegans model of alpha1-antitrypsin deficiency. PLoS ONE. 2015;10:e0141542.
PubMed PubMed Central Article CAS Google Scholar
Silverman EK, Sandhaus RA. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med. 2009;360:2749–57.
Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev. 2011;242:10–30.
CAS PubMed PubMed Central Article Google Scholar
Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest. 1991;88:891–7.
King GG, James A, Harkness L, Wark PAB. Pathophysiology of severe asthma: we’ve only just started. Respirology. 2018;23:262–71.
Lemanske RF Jr. Inflammatory events in asthma: an expanding equation. J Allergy Clin Immunol. 2000;105:S633–6.
CAS PubMed Article Google Scholar
Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160:1001–8.
CAS PubMed Article Google Scholar
Sze E, Bhalla A, Nair P. Mechanisms and therapeutic strategies for non-T2 asthma. Allergy. 2020;75:311–25.
Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis. 1988;138:327–36.
CAS PubMed Article Google Scholar
Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax. 2004;59:441–5.
Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2007;176:1215–21.
Guest PJ, Hansell DM. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol. 1992;45:260–6.
CAS PubMed Article Google Scholar
Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162:1277–84.
CAS PubMed Article Google Scholar
Cuvelier A, Muir JF, Hellot MF, Benhamou D, Martin JP, Bénichou J, et al. Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. Chest. 2000;117:415–9.
CAS PubMed Article Google Scholar
Global Strategy for Asthma Management and Prevention, 2021 [Internet]. Global Initiative for Asthma; Available from: http://www.ginasthma.org.
Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789–815.
CAS PubMed Article Google Scholar
Contoli M, Baraldo S, Marku B, Casolari P, Marwick JA, Turato G, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol. 2010;125:830–7.
Shah A, Panjabi C. Allergic aspergillosis of the respiratory tract. Eur Respir Rev. 2014;23:8–29.
Eden E, Strange C, Holladay B, Xie L. Asthma and allergy in alpha-1 antitrypsin deficiency. Respir Med. 2006;100:1384–91.
Siri D, Farah H, Hogarth DK. Distinguishing alpha1-antitrypsin deficiency from asthma. Ann Allergy Asthma Immunol. 2013;111:458–64.
CAS PubMed Article Google Scholar
Eden E, Mitchell D, Mehlman B, Khouli H, Nejat M, Grieco MH, et al. Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency. Am J Respir Crit Care Med. 1997;156:68–74.
CAS PubMed Article Google Scholar
Eden E, Hammel J, Rouhani FN, Brantly ML, Barker AF, Buist AS, et al. Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest. 2003;123:765–71.
Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med. 1994;61:461–7.
CAS PubMed Article Google Scholar
Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest. 2005;128:1989–94.
CAS PubMed Article Google Scholar
Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, et al. Does α1-antitrypsin augmentation therapy slow the annual decline in FEV1in patients with severe hereditaryα1-antitrypsin deficiency? Eur Respir J. 1997;10:2260–3.
CAS PubMed Article Google Scholar
Wencker M, Fuhrmann B, Konietzko N, Banik N. Longitudinal follow-up of patients with α1-protease inhibitor deficiency before and during therapy with IV α1-protease inhibitor. Chest. 2001;119:737–44.
CAS PubMed Article Google Scholar
Tonelli AR, Rouhani F, Li N, Schreck P, Brantly ML. Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank. Int J Chron Obstruct Pulmon Dis. 2009;4:443–52.
PubMed PubMed Central Article Google Scholar
Society AT, Society ER. ATS/ERS statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. 2003;168.
Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency. Pi Z Acta Med Scand. 1978;204:345–51.
Tobin MJ, Cook PJ, Hutchison DC. Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Chest. 1983;77:14–27.
McElvaney NG, Stoller JK, Buist AS, Prakash UB, Brantly ML, Schluchter MD, et al. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest. 1997;111:394–403.
Aiello M, Frizzelli A, Pisi R, Fantin A, Ghirardini M, Marchi L, et al. Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients. J Asthma. 2020;1–8.
Colp C, Pappas J, Moran D, Lieberman J. Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest. 1993;103:812–5.
CAS PubMed Article Google Scholar
van Veen IH, ten Brinke A, van der Linden AC, Rabe KF, Bel EH. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma. Respir Med. 2006;100:1534–9.
Montealegre F, Delgado A, Toro A, Vargas W, Chardon D, Bayona M, et al. Alfa 1 antitrypsin and protease levels in Puerto Rican asthmatics: a pilot study. P R Health Sci J. 2006;25:117–25.
Eden E, Holbrook JT, Brantly ML, Turino GM, Wise RA. Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma–results from the ALA-ACRC low-dose theophylline trial. J Asthma. 2007;44:605–8.
CAS PubMed Article Google Scholar
Miravitlles M, Vila S, Torrella M, Balcells E, Rodriguez-Frias F, de la Roza C, et al. Influence of deficient alpha1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults. Respir Med. 2002;96:186–92.
CAS PubMed Article Google Scholar
Suarez-Lorenzo I, de Castro FR, Cruz-Niesvaara D, Herrera-Ramos E, Rodriguez-Gallego C, Carrillo-Diaz T. Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites. Clin Transl Allergy. 2018;8:44.
CAS PubMed PubMed Central Article Google Scholar
Vignola AM, Bonanno A, Mirabella A, Riccobono L, Mirabella F, Profita M, et al. Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med. 1998;157:505–11.
留言 (0)